You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 275 No. 12, March 27, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cost Savings Using a Stepped-Care Prescribing Protocol for Nonsteroidal Anti-inflammatory Drugs

David L. Jones, MD, MPH; Kurt Kroenke, MD; Frank J. Landry, MD, MPH; David J. Tomich, PharmD; Richard J. Ferrel, RPh, MA

JAMA. 1996;275(12):926-930.


Abstract

Objective.
—To lower nonsteroidal anti-inflammatory drug (NSAID) costs while maintaining quality patient care and clinician satisfaction.

Design.
—Before and after 21-month trial with one study site and two control sites and a questionnaire that was sent to 203 clinicians.

Setting and Subjects.
—Two military medical centers and two affiliated primary care clinics. All beneficiaries filling outpatient NSAID prescriptions.

Interventions.
—An NSAID prescribing protocol was implemented requiring a trial of either ibuprofen or indomethacin before new prescription of more expensive NSAIDs. One control center used an NSAID computer cost-prompt and the other had no intervention.

Main Outcome Measures.
—The proportion of expensive NSAIDs prescribed at each institution and total NSAID costs adjusted for prescription volume. Clinician acceptance and patient impact were assessed by the questionnaire.

Results.
—Study site clinicians (n=158) reported very few protocol-related patient care problems. A minority (9%) of study site clinicians considered the protocol very bothersome, and only 2% felt it should be discontinued. Quarterly use of expensive NSAIDs at the study site fell from 34% to 21%, decreasing costs by 30% (P<.001). In contrast, the site with a computer cost-prompt had only a 5% decrease in NSAID costs, while costs at the site with no intervention increased 2%.

Conclusions.
—For drugs with similar benefits and adverse effects, a "stepped formulary" approach requiring an initial trial of one of the less expensive agents can maintain physician prescribing choices and satisfaction while lowering costs.

(JAMA. 1996;275:926-930)



Author Affiliations

From the Internal Medicine Service, Walter Reed Army Medical Center, Washington, DC (Dr Jones); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Md (Drs Kroenke and Landry); and Department of Pharmacy, Madigan Army Medical Center, Tacoma, Wash (Dr Tomich and Mr Ferrel).


Footnotes

The opinions or assertions contained in this article are the private views of the authors and are not to be construed as reflecting the views of the Department of the Army or the Department of Defense.

Reprint requests to Internal Medicine Service, Walter Reed Army Medical Center, 6800 Georgia Ave NW, Washington, DC 20307-5001 (Dr Jones).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prescription Drug Cost Sharing: Associations With Medication and Medical Utilization and Spending and Health
Goldman et al.
JAMA 2007;298:61-69.
ABSTRACT | FULL TEXT  

Drug Switching: The Bottom Line Isn't Always What It Seems
Whaley et al.
J Correct Health Care 2004;10:227-237.
ABSTRACT  

Ethics and Micromanaged Care
Brodell
Arch Dermatol 1996;132:1013-1015.
ABSTRACT  

STEPPED CARE APPROACH YIELDS SAVINGS IN NSAID COSTS
JWatch General 1996;1996:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.